Skip to main content
Clinical Trials/NCT04927377
NCT04927377
Completed
Not Applicable

Accessible and Inclusive Diabetes Telecoaching Self-Management Program: Protocol for a Feasibility Study

University of Alabama at Birmingham1 site in 1 country90 target enrollmentOctober 31, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabete Type 2
Sponsor
University of Alabama at Birmingham
Enrollment
90
Locations
1
Primary Endpoint
Glycemic Management
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

The purpose of this study is to develop and pilot test an accessible and inclusive Artificial Intelligence (AI)-assisted, individualized, family-focused lifestyle modification intervention (AI4DM) for glycemic control in people with disabilities.

Detailed Description

The AI4DM study will use a two-arm randomized control trial design. Eligible and consented participants will be assigned to one of two groups: 1) AI4DM intervention group with telecoaching support, and 2) attention-control group. The active intervention period will include six months of weekly and bi-weekly telecoaching calls followed by six months of follow-up and technology access, but no telecoaching calls.

Registry
clinicaltrials.gov
Start Date
October 31, 2022
End Date
September 30, 2025
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mohanraj Thirumalai

Assistant Professor

University of Alabama at Birmingham

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Type 2 Diabetes Mellitus,
  • Living with a permanent physical disability such as spinal cord injury (SCI), spina bifida, multiple sclerosis, stroke, etc.
  • Ability to converse and read in English

Exclusion Criteria

  • Current enrollment in any diabetes-related intervention
  • Severe untreated depression in the past six months
  • Major cardiac event in the past twelve months
  • Uncontrolled blood pressure
  • Resting tachycardia
  • Renal failure
  • Severe peripheral neuropathy
  • Unavailability of a smartphone

Outcomes

Primary Outcomes

Glycemic Management

Time Frame: 48 weeks

Measured using HbA1c

Secondary Outcomes

  • Family Support(48 weeks)
  • Medication Adherence(48 weeks)
  • Self-efficacy(48 weeks)
  • Health Information Technology(48 weeks)
  • Telehealth Dashboard Usability(48 weeks)
  • Health Technology Usability(48 weeks)
  • Psychological distress(48 weeks)
  • Diabetes Quality of life(48 weeks)
  • Physical Activity(48 weeks)
  • Dietary intake(48 weeks)

Study Sites (1)

Loading locations...

Similar Trials